Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence of Clostridium Difficile Infection”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableStudy completedNCT04075422
What this trial is testing

Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence.

Who this might be right for
Clostridium Difficile Infection
Fundacion SEIMC-GESIDA 869
Post-approval studies (Phase 4)Study completedNCT03466502
What this trial is testing

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Who this might be right for
Clostridium Difficile Infection
University of Nevada, Reno 104
Not applicableUnknownNCT04801862
What this trial is testing

Natural History of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionHealth Care Associated InfectionNosocomial Infection
Hospital Universitario de Valme 750
Early research (Phase 1)Study completedNCT02423967
What this trial is testing

Fresh Versus Frozen Stool for Fecal Transplant in Children

Who this might be right for
Clostridium Difficile
Mayo Clinic 28
Not applicableUnknownNCT03964844
What this trial is testing

Clostridium Difficile Infection (CDI) in Hematologic Patients.

Who this might be right for
C.Difficile Diarrhea
Hospital General Universitario Gregorio Marañon 450
Large-scale testing (Phase 3)Study completedNCT04138706
What this trial is testing

Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McGill University Health Centre/Research Institute of the McGill University Health Centre 263
Large-scale testing (Phase 3)Study completedNCT02254811
What this trial is testing

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
University of Alberta 116
Large-scale testing (Phase 3)UnknownNCT06107569
What this trial is testing

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Who this might be right for
Clostridium Difficile Infections
Hospital Universitario Evangelico de Curitiba 24
Not applicableUnknownNCT04259931
What this trial is testing

PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA

Who this might be right for
Clostridium Difficile Infection
Hospital Universitario de Cabuenes 50
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Not applicableStudy completedNCT04940468
What this trial is testing

High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myeloid, AcuteLymphoma+1 more
University of Colorado, Denver 8
Not applicableUnknownNCT01942447
What this trial is testing

Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis

Who this might be right for
Clostridium DifficileClostridium Difficile Infection
University Hospital Tuebingen 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Large-scale testing (Phase 3)Study completedNCT05201079
What this trial is testing

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Who this might be right for
Recurrent Clostridium Difficile InfectionPrimary Clostridium Difficile Infection
Mikrobiomik Healthcare Company S.L. 93
Post-approval studies (Phase 4)Study completedNCT03880539
What this trial is testing

Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
University of Kansas Medical Center 4
Large-scale testing (Phase 3)Study completedNCT03183141
What this trial is testing

ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Seres Therapeutics, Inc. 263
Large-scale testing (Phase 3)UnknownNCT02774382
What this trial is testing

Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile
Hvidovre University Hospital 450
Early research (Phase 1)Study completedNCT02865616
What this trial is testing

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
NuBiyota 19
Large-scale testing (Phase 3)Study completedNCT01241552
What this trial is testing

MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 1,452
Load More Results